Targeting the Microbiome With KB109 in Outpatients with Mild to Moderate COVID-19 Reduced Medically Attended Acute Care Visits and Improved Symptom Duration in Patients With Comorbidities

bioRxiv (2021) - Comments
doi: 10.1101/2021.03.26.21254422

John P. Haran, Yan Zheng, Katharine Knobil, Norma Alonzo Palma, Jonathan F. Lawrence, Mark A. Wingertzahn